申请人:Toray Industries, Inc.
公开号:US06492364B1
公开(公告)日:2002-12-10
Novel triazolo derivatives represented by the following formula and pharmaceutically acceptable salts thereof, as well as chemokine inhibitors containing the same as an effective component. These are useful as therapeutic agents for allergic diseases such as bronchial asthma and atopic dermatitis; therapeutic agents for inflammatory diseases such as chronic rheumatoid arthritis; therapeutic agents for autoimmune diseases such as ulcerative colitis and nephritis; and as anti-AIDS drugs.
以下是由下列公式所代表的新型三唑衍生物及其药学上可接受的盐,以及含有其作为有效成分的趋化因子抑制剂。它们可用作过敏性疾病如支气管哮喘和特应性皮炎的治疗剂;用于慢性类风湿性关节炎等炎症性疾病的治疗剂;用于溃疡性结肠炎和肾炎等自身免疫疾病的治疗剂;以及作为抗艾滋病药物。